Interferon-γ and colony-stimulating factors as adjuvant therapy for refractory fungal infections in children

被引:76
作者
Abzug, MJ
Walsh, TJ
机构
[1] Childrens Hosp, Dept Pediat, Denver, CO 80218 USA
[2] Univ Colorado, Sch Med, Denver, CO 80202 USA
[3] Natl Canc Inst, Immunocompromised Host Sect, Pediat Oncol Branch, Bethesda, MD USA
关键词
fungal infection; cytokines; interferon-gamma; colony-stimulating factor; children;
D O I
10.1097/01.inf.0000134314.65398.bf
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A human immunodeficiency virus-infected boy with Scedosporium apiospermum otomastoiditis and a girl with diabetes mellitus and Mucor sinusitis and orbital cellulitis had life-threatening disease progression despite antifungal treatment. Interferon-gamma and granulocyte-macrophage or granulocyte colony-stimulating factor were added, with good functional outcome in both children. Adjunctive therapy with interferon-gamma, granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor can be considered for refractory invasive fungal infections.
引用
收藏
页码:769 / 773
页数:5
相关论文
共 30 条
  • [1] ROLE OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AS ADJUVANT THERAPY FOR FUNGAL INFECTION IN PATIENTS WITH CANCER
    BODEY, GP
    ANAISSIE, E
    GUTTERMAN, J
    VADHANRAJ, S
    [J]. CLINICAL INFECTIOUS DISEASES, 1993, 17 (04) : 705 - 707
  • [2] Effect of cytokines on the in vitro fungicidal activity of monocytes from paracoccidioidomycosis patients
    Calvi, SA
    Peraçoli, MTS
    Mendes, RP
    Marcondes-Machado, J
    Fecchio, D
    Marques, SA
    Soares, AMVC
    [J]. MICROBES AND INFECTION, 2003, 5 (02) : 107 - 113
  • [3] Clemons K V, 2001, Semin Respir Infect, V16, P60
  • [4] The use of adjuvant interferon-γ therapy for hepatosplenic Blastoschizomyces capitatus infection in a patient with leukemia
    DeMaio, J
    Colman, L
    [J]. CLINICAL INFECTIOUS DISEASES, 2000, 31 (03) : 822 - 824
  • [5] TREATMENT OF INVASIVE PULMONARY ASPERGILLOSIS IN SEVERELY NEUTROPENIC CHILDREN WITH MALIGNANT DISORDERS USING LIPOSOMAL AMPHOTERICIN-B (AMBISOME), GRANULOCYTE-COLONY-STIMULATING FACTOR, AND SURGERY - REPORT OF 5 CASES
    DORNBUSCH, HJ
    URBAN, CE
    PINTER, H
    GINTER, G
    FOTTER, R
    BECKER, H
    MIORINI, T
    BERGHOLD, C
    [J]. PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1995, 12 (06) : 577 - 586
  • [6] Frumkin L R, 1997, Curr Opin Hematol, V4, P200
  • [7] FUKUSHIMA T, 1995, CANCER, V76, P895, DOI 10.1002/1097-0142(19950901)76:5<895::AID-CNCR2820760526>3.0.CO
  • [8] 2-F
  • [9] Comparison of interferon-γ, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor for priming leukocyte-mediated hyphal damage of opportunistic fungal pathogens
    Gaviria, JM
    van Burik, JAH
    Dale, DC
    Root, RK
    Liles, WC
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (04) : 1038 - 1041
  • [10] Modulation of neutrophil-mediated activity against the pseudohyphal form of Candida albicans by granulocyte colony-stimulating factor (G-CSF) administered in vivo
    Gaviria, JM
    van Burik, JAH
    Dale, DC
    Root, RK
    Liles, WC
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (05) : 1301 - 1304